Market Research Logo

Global Acne Market: Industry Analysis & Outlook (2017-2021)

Global Acne Market: Industry Analysis & Outlook (2017-2021)

Acne is defined as a chronic skin disorder in which the hair follicles become blocked and/or inflamed. There are several variants of acne and they range from mild to severe. The most common type of acne is acne vulgaris (vulgaris means common). Acne appears most often on the face, but can also be a nuisance on chest, back, and upper arms. Although usually not considered a dangerous medical condition, acne can cause psychological distress and even skin scarring. Teenagers are the most commonly affected group with around 85% of 16-18 year olds believed to have some form of acne. However, some people may suffer from acne well into their 30s and 40s even.

The global acne market is set to experience favorable growth driven by factors such as increasing youth population, upsurge in disposable income, rising health care expenditure and growing sedentary lifestyle. The major trends observed in this market include technological advancements, rising preference for minimally invasive procedures and increasing awareness programs about acne. However, the growth of this market is constrained by challenges such as entry of generic drugs, side effects of acne therapies and stringent regulations.

The report “Global Acne Market: Industry Analysis & Outlook (2017-2021)” analyses the development of the market, with focus on the US and European markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Valeant Pharmaceuticals International, Inc., Reckitt Benckiser Group Plc., Allergan Plc. And GlaxoSmithKline Plc. are being profiled along with their key financials and strategies for growth.


1. Overview
1.1 Introduction
Table 1: Types of Acne
1.2 Causes and Symptoms
1.3 Severity of Acne
1.4 Treatment
Table 2: Treatment for Acne
2. Global Acne Market
2.1 Global Acne Market Forecast by Value
Table 3: Global Acne Market Forecast by Value (2016-2021)
2.2 Global Acne Market by Type
Table 4: Global Acne Market by Type (2016)
2.2.1 Global Inflammatory Acne Market Forecast by Value
Table 5: Global Inflammatory Acne Market Forecast by Value (2016-2021)
2.2.2 Global Non-Inflammatory Acne Market Forecast by Value
Table 6: Global Non-Inflammatory Acne Market Forecast by Value (2016-2021)
2.3 Global Acne Patient Volume Forecast
Table 7: Global Acne Patient Volume Forecast (2016-2021)
3. Regional Market Analysis
3.1 The US
3.1.1 The US Acne Market Forecast by Value
Table 8: The US Acne Market Forecast by Value (2016-2021)
3.1.2 The US Acne Market by Drug Type
Table 9: The US Acne Market by Drug Type (2016)
3.1.3 The US Acne Topical Drugs by Brand
Table 10: The US Acne Topical Drugs by Brand (2016)
3.1.4 The US Acne Oral Antibiotics by Brand
Table 11: The US Acne Oral Antibiotics by Brand (2016)
3.1.5 The US Moderate to Severe Market Forecast by Value
Table 12: The US Moderate to Severe Acne Market Forecast by Value (2016-2021)
3.1.6 The US Topical Retinoid Market Forecast by Value
Table 13: The US Topical Retinoid Market Forecast by Value (2016-2021)
3.1.7 The US Isotretinoin Market Forecast by Value
Table 14: The US Isotretinoin Market Forecast by Value (2016-2021)
3.1.8 The US Minocycline Market Forecast by Value
Table 15: The US Minocycline Market Forecast by Value (2016-2021)
3.1.9 The US Moderate to Severe Annual Prescriptions Forecast
Table 16: The US Moderate to Severe Annual Prescriptions Forecast (2016-2021)
3.1.10 The US Topical Retinoid Annual Prescriptions Forecast
Table 17: The US Topical Retinoid Annual Prescriptions Forecast (2016-2021)
3.1.11 The US Isotretinoin Annual Prescriptions Forecast
Table 18: The US Isotretinoin Annual Prescriptions Forecast (2016-2021)
3.1.12 The US Minocycline Annual Prescriptions Forecast
Table 19: The US Minocycline Annual Prescriptions Forecast (2016-2021)
3.1.13 The US Acne Patient Volume Forecast
Table 20: The US Acne Patient Volume Forecast (2016-2021)
3.1.14 The US Moderate to Severe Acne Patient Volume Forecast
Table 21: The US Moderate to Severe Acne Patient Volume Forecast (2016-2021)
3.1.15 The US Acne Treated Patient Volume Forecast
Table 22: The US Acne Treated Patient Volume Forecast (2016-2021)
3.2 The US Acne Drugs Revenue
3.2.1 The US FMX-101 Drug Revenue Forecast
Table 23: The US FMX-101 Drug Revenue Forecast (2020-2024)
3.2.2 The US SNA-001 Drug Revenue Forecast
Table 24: The US SNA-001 Drug Revenue Forecast (2020-2024)
3.2.3 The US DRM-01 Drug Revenue Forecast
Table 25: The US DRM-01 Drug Revenue Forecast (2020-2024)
3.3 Europe
3.3.1 Europe Acne Patient Volume Forecast
Table 26: Europe Acne Patient Volume Forecast (2016-2021)
3.3.2 Europe Moderate to Severe Acne Patient Volume Forecast
Table 27: Europe Moderate to Severe Acne Patient Volume Forecast (2016-2021)
3.3.3 Europe Acne Treated Patient Volume Forecast
Table 28: Europe Acne Treated Patient Volume Forecast (2016-2021)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increasing Youth Population
Table 29: Global Youth Population (2010-2025)
4.1.2 Upsurge in Disposable Income
Table 30: Global GNI Per Capita (2012-2016)
4.1.3 Rising HealthCare Expenditure
Table 31: Global HealthCare Expenditure Per Capita (2012-2016)
4.1.4 Growing Sedentary Lifestyle
4.2 Key Trends & Developments
4.2.1 Technological Advancements
4.2.2 Rising Preference for Minimally Invasive Procedures
4.2.3 Increasing Awareness Programs
4.3 Challenges
4.3.1 Entry of Generic Drugs
4.3.2 Side Effects of Acne Therapies
4.3.3 Stringent Regulations
5. Competitive Landscape
5.1 Global Market
5.1.1 Global Acne Market- Revenue and Market Cap Comparison
Table 32: Global Acne Market - Revenue & Market Cap Comparison (2016)
5.1.2 Global Acne Market- Drug Comparison by Company
Table 33: Global Acne Market- Drug Comparison by Company (2016)
5.1.3 Global Late Stage Acne Market- Drug Comparison by Company
Table 34: Global Late Stage Acne Market- Drug Comparison by Company (2016)
5.1.4 Global Mid Stage Acne Market- Drug Comparison by Company
Table 35: Global Mid Stage Acne Market- Drug Comparison by Company (2016)
6. Company Profiles
6.1 Valeant Pharmaceuticals International, Inc.
6.1.1 Business Overview
Table 36: Valeant Pharmaceuticals Revenue by Segments (2016)
6.1.2 Financial Overview
Table 37: Valeant Pharmaceuticals Revenue and Net Loss (2012-2016)
6.1.3 Business Strategies
Table 38: Valeant Pharmaceuticals Research & Development Expenses (2014-2016)
Table 39: Valeant Pharmaceuticals Agreements (2017)
6.2 Reckitt Benckiser Group Plc.
6.2.1 Business Overview
Table 40: Reckitt Benckiser Revenue by Segments (2016)
6.2.2 Financial Overview
Table 41: Reckitt Benckiser Revenue and Net Income (2012-2016)
6.2.3 Business Strategies
Table 42: Reckitt Benckiser R&D Expenses (2014-2016)
6.3 Allergan Plc.
6.3.1 Business Overview
Table 43: Allergan Plc. Revenue by Segment (2016)
6.3.2 Financial Overview
Table 44: Allergan Plc. Revenue and Net Income (2012-2016)
6.3.3 Business Strategies
Table 45: Allergan Plc. R&D Expenses (2013-2016)
6.4 GlaxoSmithKline Plc.
6.4.1 Business Overview
Table 46: GlaxoSmithKline Plc. Revenue by Segments (2016)
6.4.2 Financial Overview
Table 47: GlaxoSmithKline Plc. Revenue and Net Profit (2012-2016)
6.4.3 Business Strategies

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report